Results 191 to 200 of about 10,834,348 (379)
Mythology in the Middle Ages: Heroic Tales of Monsters, Magic, and Might
Myths of gods, legends of battles, and folktales of magic abound in the heroic narratives of the Middle Ages. Mythology in the Middle Ages: Heroic Tales of Monsters, Magic, and Might describes how Medieval heroes were developed from a variety of source ...
Fee, Christopher R.
core
International Learning Partnership: Living History and Adult Education in the Museum
Many archaeological open-air museums and museums with indoor reconstructions choose to interpret history using the method of ‘living history’, or re-enactments. If one only counts the German references, there is wide variety of terms used by museums when
Susanne Wiermann
doaj
Book Review: VI. Miscellaneous: A History of Classical Scholarship from the Sixth Century B. C. to the End of the Middle Ages [PDF]
A. T. Robertson
openalex +1 more source
Author Correction: Spotted phenotypes in horses lost attractiveness in the Middle Ages. [PDF]
Wutke S+16 more
europepmc +1 more source
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef+10 more
wiley +1 more source
The Growth of English Industry and Commerce During the Early and Middle Ages.B. W. Cunningham [PDF]
Victor E. Helleberg
openalex +1 more source
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon+13 more
wiley +1 more source
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim+11 more
wiley +1 more source